Home LiteratureArticle Details
PMID: 2168976 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature.

Journal of virology ·Vol. 64 ·No. 10 ·1990-10-00 ·Pages 4922-9

Christodoulou C, Colbere-Garapin F, Macadam A, Taffs LF, Marsden S, Minor P, Horaud F

Abstract

Poliovirus type 1 neurovirulence is difficult to analyze because of the 56 mutations which differentiate the neurovirulent Mahoney strain from the attenuated Sabin strain. We have isolated four neurovirulent mutants which differ from the temperature-sensitive parental Sabin 1 strain by only a few mutations, using selection for temperature resistance: mutant S(1)37C1 was isolated at 37.5 degrees C, S(1)38C5 was isolated at 38.5 degrees C, and S(1)39C6 and S(1)39C10 were isolated at 39.5 degrees C. All four mutants had a positive reproductive capacity at supraoptimal temperature (Rct+ phenotype). Mutant S(1)37C1 induced paralysis in two of four cynomolgus monkeys, and the three other mutants induced paralysis in four of four monkeys. The lesion score increased from the S(1)37C1 mutant to the S(1)39 mutants. To map the mutations associated with thermoresistance and neurovirulence, we sequenced all regions in which the Sabin 1 genome differs from the Mahoney genome. The S(1)37C1 mutant had one mutation in the 5' noncoding region and another in the 3' noncoding region. Mutant S(1)38C5 had these mutations plus another mutation in the 3D polymerase gene. The S(1)39 mutants had three additional mutations in the capsid protein region. The mutations were located at positions at which the Sabin 1 and Mahoney genomes differ, except for the mutation in the 5' noncoding region. The noncoding-region mutations apparently confer a low degree of neurovirulence. The 3D polymerase mutation, which distinguishes S(1)38C5 and S(1)39 mutants from S(1)37C1, is probably responsible for the high neurovirulence of S(1)38C5 and S(1)39 mutants. The capsid region mutations may contribute to the neurovirulence of the S(1)39 mutants, which was the highest among the mutants.

MeSH Terms
Animals Capsid/biosynthesis,isolation & purification Cell Line Codon/genetics Electrophoresis, Gel, Two-Dimensional Electrophoresis, Polyacrylamide Gel Humans Macaca fascicularis Mutation Phenotype Poliovirus/genetics,pathogenicity Poliovirus Vaccine, Oral RNA, Viral/genetics,isolation & purification Viral Proteins/biosynthesis,isolation & purification Virulence/genetics
Chemicals
Codon Poliovirus Vaccine, Oral RNA, Viral Viral Proteins
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Christodoulou C
Unité de Virologie Médicale, Institut Pasteur, Paris, France.
Colbere-Garapin F
Macadam A
Taffs L F
Marsden S
Minor P
Horaud F
References (41)
41 references, click to expand
  1. Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants.
    J Mol Biol. 1984 Apr 25;174(4):561-85 PMID: 6202874
  2. Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y.
    J Virol. 1989 May;63(5):2357-60 PMID: 2539524
  3. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  4. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
    Dev Biol Stand. 1985;60:343-7 PMID: 2995173
  5. In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain.
    J Virol. 1985 Mar;53(3):786-92 PMID: 2983090
  6. Poliovirus-specific polypeptides in infected HeLa cells analysed by isoelectric focusing and 2D-analysis.
    J Gen Virol. 1981 Jan;52(Pt 1):61-9 PMID: 6267176
  7. Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice.
    EMBO J. 1988 Sep;7(9):2839-47 PMID: 2460345
  8. A poliovirus temperature-sensitive RNA synthesis mutant located in a noncoding region of the genome.
    Proc Natl Acad Sci U S A. 1986 Feb;83(3):571-5 PMID: 3003739
  9. Genetic analysis of the attenuation phenotype of poliovirus type 1.
    J Virol. 1986 May;58(2):348-58 PMID: 3009852
  10. Considerations in the preparation and use of poliomyelitis virus vaccine.
    J Am Med Assoc. 1955 Aug 6;158(14):1239-48 PMID: 14392073
  11. Parameters for differentiating vaccine-derived and wild poliovirus strains.
    Prog Med Virol. 1978;24:178-206 PMID: 212784
  12. The influence of technique on the sensitivity of monkeys to intraspinally inoculated poliovirus.
    J Hyg (Lond). 1961 Dec;59:395-9 PMID: 13868598
  13. Synthesis of plus- and minus-strand RNA from poliovirion RNA template in vitro.
    J Virol. 1986 Jun;58(3):790-6 PMID: 3009887
  14. Studies on the attenuation of the Sabin type 3 oral polio vaccine.
    J Virol Methods. 1987 Aug;17(1-2):183-9 PMID: 2822753
  15. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine.
    J Virol. 1989 Mar;63(3):1338-44 PMID: 2536836
  16. Recombinants between attenuated and virulent strains of poliovirus type 1: derivation and characterization of recombinants with centrally located crossover points.
    Virology. 1985 Jun;143(2):467-77 PMID: 2998022
  17. DNA sequencing with chain-terminating inhibitors.
    Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 PMID: 271968
  18. Internal binding of eucaryotic ribosomes on poliovirus RNA: translation in HeLa cell extracts.
    J Virol. 1989 Jan;63(1):441-4 PMID: 2535747
  19. Primary structure, gene organization and polypeptide expression of poliovirus RNA.
    Nature. 1981 Jun 18;291(5816):547-53 PMID: 6264310
  20. Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1.
    J Virol. 1986 Aug;59(2):377-83 PMID: 3016304
  21. Poliovirus neurovirulence.
    Adv Virus Res. 1988;34:217-46 PMID: 2843017
  22. [Inhibition of the development of poliomyelitis virus at 39 degrees & the problem of the role of hyperthermia in the evolution of viral infections].
    C R Hebd Seances Acad Sci. 1958 Jan 6;246(1):190-2 PMID: 13511775
  23. Intertypic genomic rearrangements of poliovirus strains in vaccinees.
    Virology. 1988 Dec;167(2):507-14 PMID: 2849237
  24. Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome.
    Proc Natl Acad Sci U S A. 1981 Aug;78(8):4887-91 PMID: 6272282
  25. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome.
    Nature. 1985 Apr 11-17;314(6011):548-50 PMID: 2986004
  26. Genetic variation occurring on the genome of an in vitro insertion mutant of poliovirus type 1.
    J Virol. 1989 Mar;63(3):1069-75 PMID: 2536821
  27. The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: molecular and structural effects of a mutation in the capsid protein VP3.
    J Gen Virol. 1989 May;70 ( Pt 5):1117-23 PMID: 2543771
  28. Death and transfiguration of a problem.
    Bacteriol Rev. 1969 Sep;33(3):390-403 PMID: 4313270
  29. Conserved structural domains in the 5'-untranslated region of picornaviral genomes: an analysis of the segment controlling translation and neurovirulence.
    Virology. 1989 Feb;168(2):201-9 PMID: 2536978
  30. Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I.
    Science. 1988 Jul 8;241(4862):213-5 PMID: 2838906
  31. New model for the secondary structure of the 5' non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence.
    J Mol Biol. 1989 May 20;207(2):379-92 PMID: 2547075
  32. Addition of a foreign oligopeptide to the major capsid protein of poliovirus.
    Proc Natl Acad Sci U S A. 1988 Nov;85(22):8668-72 PMID: 2460875
  33. 3'-terminal nucleotide sequence of encephalomyocarditis virus RNA determined by reverse transcriptase and chain-terminating inhibitors.
    Proc Natl Acad Sci U S A. 1978 Sep;75(9):4257-61 PMID: 81487
  34. Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing.
    J Virol. 1986 Feb;57(2):515-25 PMID: 3003384
  35. Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype.
    J Virol. 1989 Mar;63(3):1302-9 PMID: 2536835
  36. Analysis of RNA synthesis of type 1 poliovirus by using an in vitro molecular genetic approach.
    J Virol. 1987 Sep;61(9):2816-22 PMID: 3039171
  37. Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b.
    Proc Natl Acad Sci U S A. 1984 Mar;81(5):1539-43 PMID: 6324200
  38. Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine.
    Nucleic Acids Res. 1984 Oct 25;12(20):7787-92 PMID: 6093054
  39. Role of 3'-end sequences in infectivity of poliovirus transcripts made in vitro.
    J Virol. 1989 Jan;63(1):467-70 PMID: 2535751
  40. Measurement of poliovirus RNA polymerase binding to poliovirion and nonviral RNAs using a filter-binding assay.
    Nucleic Acids Res. 1988 Nov 11;16(21):10339-52 PMID: 2461545
  41. Factors influencing the evolution of viral diseases at the cellular level and in the organism.
    Bacteriol Rev. 1959 Sep;23(3):109-24 PMID: 14419105
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1990-10-00
Pages
4922-9
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC247983
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com